| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| July 17, 2026 | ±2.4% | +9.2% | under-priced |
| April 16, 2026 | ±1.9% | -0.2% | over-priced |
| October 16, 2025 | ±2.8% | -2.9% | under-priced |
| July 17, 2025 | ±1.6% | +3.8% | under-priced |
| April 16, 2025 | ±3.5% | +1.1% | over-priced |
| October 17, 2024 | ±1.7% | +9.0% | under-priced |
| July 19, 2024 | ±1.8% | -7.8% | under-priced |
| April 17, 2024 | ±1.6% | -7.4% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $10.26 | $12.2B | $2.2B |
| Q1 FY2026 | $7.78 | $11.9B | $1.7B |
| Q4 FY2025 | $10.98 | $12.4B | $2.5B |
| Q3 FY2025 | $8.24 | $12.5B | $1.9B |
The Travelers Companies, Inc. (TRV) reports in 103 days, with the next report estimated for November 8, 2026. Across the last 8 reports, options priced an average ±2.2% earnings move while the stock actually moved 5.2% on average — the market has tended to under-price TRV's earnings risk. Fundamentals into the print: EPS up 57.1% year-over-year, revenue up 0.3%. QuantLogix's live 5-factor engine currently reads TRV as a buy at 63/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →